Survey domains demonstrated more than a weak correlation with visual field impairment. The VF-14 scores were moderately correlated (r=-0.58). Of the National Eye Institute-Visual Functioning Questionnaire scales, peripheral vision (r=\m=-\0.60), distance activities (r=\m=-\0.56), and vision-specific dependency (r=\m=-\0.56) were moderately correlated with visual field impairment; vision-specific social functioning, near activities, vision-specific role difficulties, general vision, vision-specific mental health, color vision, and driving were modestly correlated with visual field impairment (r value between \m=-\0.32and \m=-\0.55); visual pain was weakly correlated with visual field impairment; and general health and vision\x=req-\ specific expectations were not notably correlated with visual field impairment. Statistically adjusting for visual acuity weakened the correlations. The Medical Outcomes Study 36-Item Short Form Health Survey indicated that our patients with glaucoma were comparable with previously studied patients without severe systemic medical problems. However, the Medical Outcomes Study 36-Item Short Form Health Survey scores did not correlate with visual field impairment in our study. Based on the moderate correlation between binocular visual field impairment with the VF-14 and the National Eye Institute-Visual Functioning Questionnaire, these questionnaires may be useful among patients with glaucoma. Arch Ophthalmol. 1997; 115:1447 -1455 Studies evaluating the functional status and quality of life of ophthalmic patients have focused on the effects of cataract1"11 and retinal disease.12 One study evaluated "per¬ ceived visual disability" among 50 pa¬ tients with primary open-angle glau¬ coma, but only 16 paraphrased versions of the 84 questions used were published and quality of life was not assessed. ' 
QUESTIONNAIRES
For all quality-of-life scales, the highest possible score, 100, represents the highest level of functioning or the minimal sub¬ jective impairment. The SF-36',klwp" includes 1 multi-item scale that assesses 8 health concepts: ( 1 ) limitations in physi¬ cal activities because of health problems, (2) limitations in social activities because of physical or emotional problems, (3) limitations in usual role activities because of physical health problems, (4) bodily pain, (5) general mental health (psycho¬ logical distress and well-being), (6) limitations in usual role activities because of emotional problems, (7) vitality (energy and fatigue), and (8) general health perceptions. This ques¬ tionnaire was chosen to assess global health-related quality of life because its validity and reliability have been demon¬ strated repeatedly.1 ,(lhap7,)"3' Further, comparative normative data are available for the general populations in the United States1''*'1'101·20'2252'3 and for patients with various medical con¬ ditions, including hypertension, congestive heart failure, type 2 diabetes mellitus, acute myocardial infarction, and clinical depression.1,<chai,K"
The VF-14 was developed to identify a broad spec¬ trum of vision-dependent activities performed in every¬ day life that can be affected by cataract.4 It was selected as one measure of patients' vision-specific functioning be¬ cause it has been shown to be a reliable and valid measure of functional impairment due to cataract and provides in¬ formation not conveyed by visual acuity.1'4
The 51-item field test version of the NEI-VFQi4 was de¬ signed to evaluate patients' perceptions of the effect of ocu¬ lar disease on daily functioning and quality of life. Unlike the VF-14, the NEI-VFQ assesses patients' abilities to per¬ form a broader range of tasks and was designed for ophthal¬ mic patients in general rather than for patients with cata¬ ract. The NEI-VFQ consists of the following 13 subscales: gen¬ eral health, general vision, visual pain, near activities, distance activities, vision-specific social functioning, vision-specific mental health, vision-specific expectations, vision-specific role difficulties, vision-specific dependency, driving, color vision, and peripheral vision.
PROCEDURES
The study was approved by the Medical Sciences Subcommit¬ tee for the Protection of Human Subjects at the University of Miami School of Medicine. Because a considerable proportion of patients speak only Spanish, the VF-14 and NEI-VFQ were translated into Spanish'' and, to ensure accuracy, translated back into English by a different translator. The SF-36 has al¬ ready been published in Spanish. One hundred one patients completed the English versions, and 46 patients completed the Spanish versions.
After informed consent was obtained, each study partici¬ pant was asked to self-administer the SF-36, VF-14, and NEI-VFQ questionnaires. If the patient's vision prohibited selfadministration, the questionnaires were administered by a trained interviewer or a companion of the patient. Of the 147 patients, 16 (11%) required assistance. Ifitems were left blank, our clinical coordinator telephoned the patient to obtain fur¬ ther information. One ophthalmologist (R.K.P.), who was un¬ aware of the patients' questionnaire scores, performed the ophthalmologic examinations. Snellen visual acuity (with usual corrective lenses), type and duration of glaucoma, previous laser and incisional ocular surgeries for the treatment of glau¬ coma, number of current glaucoma medications, and comorbidities were abstracted from patients' medical records and the NEI-VFQ.
Binocular simultaneous visual field testing was performed with an automated perimeter (Humphrey Visual Field Ana¬ lyzer, Humphrey Instruments, San Leandro, Calif), which was equipped with the Esterman program. 14i<°' Testing was performed with patients wearing their usual contact lenses or glasses to assess everyday vision. Visual fields were status is relevant. This study investigated (1) (3) the aspects of quality of life that are most affected by the visual impairment associ¬ ated with glaucoma; and (4) the association between previously reported risk factors and quality-of-life ques¬ tionnaires. evaluated using the binocular Esterman visual field score be¬ cause the development of this score was based on function rather than anatomy; that is, rather than all parts of the visual field being given equal value, points in the central and lower fields are represented more heavily, as these areas of the visual field are believed to be used preferentially for human activities."' For example, the Esterman visual field of a patient is shown in Figure 1 , A; the patient's previously obtained Humphrey visual fields 24-2 are shown in Figure 1 , B, and Figure 1 , C.
RESULTS

SUMMARY STATISTICS
The dense nasal step of the right eye is not detected on the Es¬ terman test. The overlapping portion of the normal nasal vi¬ sual field of the left masks the defect of the right eye. A total of 102 of the 120 stimuli were seen, and the calculated Ester¬ man efficiency score was 85. The percentage of binocular vi¬ sual field impairment is calculated by subtracting the Ester¬ man score from 100; in this example, the value equals 15%.
The visual acuity impairment of the patients was calculated using the 3-step method described in the American Medical Association's Guides to the Evaluation ofPerntanent Impairment,w the accepted national standard. For these objective visual func¬ tion measures, the lowest possible score, 0, represents the high¬ est level of functioning or the minimum impairment (a visual acuity of 20/20 in each eye). To assess nonophthalmic comorbidities, the NEI-VFQ field test''health status survey was administered. Patients were asked if they suffered from any of 16 health conditions. To as¬ sess better the effect of comorbidities on patients' functioning, a scale was added to the NEI-VFQ comorbidity assessment; for each comorbidity reported, patients were asked to specify how much that condition interfered with their activities (eg, general functioning). A comorbidity score was then assigned to each of these responses ( 1, not at all; 2, a little; and 3, a great deal). An overall comorbidity score for each patient was com¬ puted by summing the scores. Thus, the minimum possible comorbidity score was 0, indicating an otherwise healthy pa¬ tient, and the maximum score was 48, indicating a patient with notable nonophthalmic health problems. No other attempt was made to rate the severity of the comorbidities. A similar comorbidity scale has been published previously.12
STATISTICAL METHODS
The distribution of all variables in the study population was examined with frequency tables and summary statistics. Bivariate relationships among the dependent variables objective visual function measures and each of the qualityof-life scales), and between the dependent variables and the continuous independent variables, were studied with scatterplots and quantified with an rvalue, the Pearson In a study of this size, even weak correlations attain statistical significance, so the value does not constitute a useful measure of the importance of a relationship.
Correlations were classified into ranges of importance: not statistically significant; significant, but weak, |r|<0.32 (r2<10%) (P<.05); modest, |r| from 0.32 to 0.55 (r2 from 10%-30%); and moderate, |r|>0.55 (r2>30%). In the case of a dichotomous variable, such as sex, correlated with a continuous variable (any of the quality-of-life measures), the following approximate equivalence holds between the Pearson correlation coef¬ ficient, r, and the difference in mean values between the 2 groups, assuming equal numbers and homogeneity of variance in both groups:
where s indicates the within-group SD. Therefore, an r value of 0.32 (r2=10%) corresponds to a ratio of the dif¬ ference between means to the pooled sample SD of approximately 0.68, or roughly two thirds. This corre¬ sponds to a medium effect size for the comparison of 2 means in the terminology of Cohen.42 The distribution of visual field impairment scores is shown in Figure 2 . This figure demonstrates that more than 75% of the patients had less than 50% loss of binocular visual field. The relationship between visual acuity impairment and binocular visual field impairment is demonstrated in Figure 3 (r=0.54).
The mean values for the SF-36, the VF-14, and the NEI-VFQ are provided in Table 3 . To evaluate the global quality of life of our study patients relative to other populations, we compared SF-36 scores.
For each domain of the SF-36, the scores of our patients with glaucoma were within 10% of age-adjusted normal values. l5(chaPio) The published values for physical functioning, role-physical, and general health scales of patients with a severe comorbid condition, congestive heart failure, were at least 20% worse than the scores of the patients in this study.l3<chapl0) However, values for all scales of our study patients were comparable with those of patients with hypertension, a common condition that is not usually associated with severe systemic symp¬ toms.15(chapl0) Table 4 provides the strength of the Pearson correlation coefficients between the clinical or demographic variables and the questionnaire scores. None of these variables was more highly correlated with any of the vision-related quality-of-life scores than was visual field or visual acuity impairment (Table 5 ). 
CORRELATIONS BETWEEN VISUAL FIELD
IMPAIRMENT AND QUALITY-OF-LIFE QUESTIONNAIRES Table 5 provides the magnitude of the correlations be¬ tween visual acuity impairment and visual field impair¬ ment with each of the quality-of-life questionnaires. The strongest correlations were between visual field impair¬ ment and the NEI-VFQ peripheral vision subscale (r=-0.60), the VF-14 (r=-0.58), the NEI-VFQ distance activities subscale (r=-0.56), and the NEI-VFQ visionspecific dependency subscale (r=-0.56). Figure 4 and Figure 5 are examples of 2 of these scatterplots. After correcting for visual acuity impairment with partial cor¬ relation methods, some of the correlations between vi¬ sual field impairment and quality-of-life questionnaire scores were reduced ( Table 4 did not appreciably change the correlations between visual field impairment scores adjusted for visual acuity and questionnaire scores (r2 changed <0.04). To indicate the effect of a unit change in visual field impairment score (percentage) on the ques¬ tionnaire score, Table 3 also provides the slopes. COMMENT An objective measurement of visual acuity or visual field may not accurately reflect the actual or perceived ability of the patient to function. Several suggestions have been made that visual acuity alone may be inadequate as an indicator of the degree of visual impairment. Genen-sky43 argued that "the definition of legal blindness in this country, based so heavily on distance visual acuity, has done more harm to partially sighted people than any other definition used by our federal and state governments." Cullinan44 concluded, in a survey of 193 visually dis¬ abled people in England and Wales, that the level of vi¬ sual acuity provided no accurate guide to what could be achieved visually or to the extent of the handicap expe¬ rienced.
VF-14
Although the VF-14 was developed as an instrument to measure the visual functioning of patients with cataracts, the VF-14 scores of patients with glaucoma in this study were modestly correlated with visual field impairment scores, after correcting for visual acuity. Because a suffi¬ ciently large visual field may be necessary to perform many of the visually related tasks described in the VF-14, pa¬ tients with substantially reduced visual fields may not have been able to perform them. Although there was a moder¬ ate correlation between visual field impairment and vi¬ sual acuity impairment (r=0.54) in this study, some pa¬ tients with excellent visual acuity had high degrees of visual field impairment and others with poor visual acuity had relatively less impaired visual field scores (Figure 3 ). The VF-14 scores of patients in this study were moderately cor¬ related with visual field impairment scores. This sup¬ ports the use of the VF-14 to assess vision-specific func¬ tioning in patients with glaucoma as well as cataract. Binocular Visual Acuity Impairment. % Figure 3 . A scatterplot of the American Medical Association (AMA) visual acuity impairment score with the Esterman binocular visual field impairment score (t=0.54).
MEDICAL OUTCOMES STUDY 36-ITEM SHORT FORM HEALTH SURVEY
The 8 domains of the SF-36 were only weakly corre¬ lated with visual acuity impairment or visual field impairment. This is not surprising considering that the SF-36 was developed as a global quality-of-life instrument rather than a diseaseor organ systemspecific measurement. Although the SF-36 scores were not substantively correlated with visual impairment, the comparable values of patients in this study with age-adjusted values suggest that the general health of the participants was similar to previously studied tSlope of change in questionnaire score (dependent variable) with increase in visual field impairment score. patients and that the visual impairment of glaucoma did not contribute additional effect.I5(chapl0)
NATIONAL EYE INSTITUTE-VISUAL
FUNCTIONING QUESTIONNAIRE
The questions regarding peripheral vision and the subscales for distance activities, vision-specific depen¬ dency, vision-specific social functioning, near activi¬ ties, vision-specific role difficulties, general vision, vision-specific mental health, color vision, and driving were at least modestly associated with visual field impairment. When corrected for visual acuity, the cor¬ relation coefficients between visual field impairment and general vision, near activities, and color vision decreased from the range of modest, r=0.32 to r=0.55 (r2=10%-30%) to weak, r<0.32 (H<10%); general health remained not correlated. The finding that the NEI-VFQ peripheral vision, distance activities, and vision-specific dependency subscales are correlated moderately with visual field impairment supports the continued use of this questionnaire for patients with glaucoma.
ADJUSTED ANALYSES
In this study, visual field impairment was moderately correlated with visual acuity impairment. This correla¬ tion could be due to the influence of glaucoma on both measures of visual function, the influence of some other ocular pathological features, such as cata¬ ract, or both. In the first case, the unadjusted correla¬ tions between visual field impairment and question¬ naire scales are appropriate. In the second case, the relationships between questionnaire scores and visual Table 3 . 1 indicates a modest negative and statistically significant Pearson correlation (r=-0.32 to -0.55); 2, a weak negative and statistically significant Pearson correlation (r< -0.32); 3, a weak positive and statistically significant Pearson correlation (r< 0.32); 4, a modest positive and statistically significant Pearson correlation (r=0.32 to 0.55); and ellipses, no correlation.
t Primary open-angle glaucoma was coded as 1 and other types as 0; therefore, a negative correlation indicates that patients with primary open-angle glaucoma had a lower score on the NEI-VFQ GH scale than patients with other types of glaucoma.
XHispanlc ethnicity was coded as follows: Hispanic=1, and white=0. Therefore, a positive correlation indicates that Hispanics enjoyed a higher score on the SF-36 V scale than non-Hispanic whites.
§Living status was coded as 11f married or living with a significant other and as 0 if otherwise. Therefore, a positive correlation indicates that patients who were married or living with a significant other had higher questionnaire scores than others. field impairment are interpreted best after adjusting for visual acuity impairment. In the third situation, neither analysis is entirely satisfactory. In this study, we have not attempted to discriminate between differ¬ ent causes of visual acuity impairment; in any event, the true relationship between visual field loss and the questionnaire scores will be within the bounds of the unadjusted and adjusted correlation estimates (Table 5 ).
No patient characteristics were more highly cor¬ related with any of the vision-related quality-of-life measurements than was binocular visual acuity impairment itself. The age of patients in this study was correlated in the 10% to 30% range with the physical functioning domain of the SF-36. This finding is con¬ sistent with the published normative values that docu¬ ment decreased scores in the physical functioning domain with advancing age.13tchaP10) No relationship could be defined between the number of glaucoma medications and any of the quality-of-life measure¬ ments. However, medication effects are likely to exist and may be found if sought in a systematic, prospec¬ tive manner. Further statistical adjustment for patient characteristics other than visual acuity impairment did not substantially affect the correlations between visual field impairment and questionnaire scores.
LIMITATIONS OF THE STUDY
By the referral nature of the practice, our patients were likely to have had more severe glaucoma associated with surgical interventions than most patients with glaucoma. However, our study population includes patients with a wide range of visual field impairment, and more than half the patients had visual field impairment scores of 20% or less. In any case, the rela¬ tionship between questionnaire scores and visual field impairment seems consistent throughout the range of impairment. Also, for patients who could not selfadminister the questionnaire, a companion or clinical assistant read aloud the questions and recorded the patient's responses. This technique may have intro¬ duced a bias that affected the response of the patient.
However, in a previous study involving patients with glaucoma, Mills and Drance14 explored this possibility by administering disability questionnaires separately to the patients and their companions. In no instance did the companion's response to the questionnaire notably disagree with that of the patient.
CONCLUSIONS
In this study of patients with glaucoma, the VF-14 and the NEI-VFQ, measures assessing vision-specific func¬ tioning and quality of life, were more sensitive to visual field impairment than the SF-36. The SF-36, a global quality-of-life measure, indicated that our patients with glaucoma were comparable with previ¬ ously studied patients without severe systemic medical problems. Because the early stages of glaucoma usually do not produce symptoms, it is not surprising that many of the scales, either vision specific or global, did not demonstrate strong correlations with visual field or acuity impairment. Thus, the questionnaire chosen should be based on what the investigators or clinicians are most interested in knowing about their patients. For investigators interested in vision-specific function¬ ing, the VF-14 provides a concise measure. However, a measure such as the NEI-VFQ may be more useful for investigators interested in evaluating multiple dimen-Downloaded From: http://jamanetwork.com/ by a University of California -Los Angeles User on 09/25/2017 Table 5 . Pearson Correlations (r) for VF-14, SF-36, and NEI-VFQ With the AMA Binocular Visual Acuity Impairment Score and Binocular Visual Field Impairment Score (Unadjusted and Adjusted)* Questionnaire Scale AMA Visual Acuity Impairment Score Visual Field Impairment Score Unadjusted Adjusted! "Definitions forali the questionnaire scales are given in Table 3 .
AMA indicates American Medical Association.
[Adjusted for the AMA visual acuity impairment score.
[Moderate correlation, \t\>0.55 (P<.001). §Modest correlation, 0.32s\r\s0.55 (P<.001). \\Weakcorrelation, \r\<0.32(P<.05). sions of vision-related quality of life. An important aspect of the study is the use of the binocular visual field. Although clinicians will continue to analyze uniocülar visual fields to monitor glaucoma progression, we believe that the binocular visual field provides more realistic information about the visual field a patient uses for performing daily activities.
To describe quality of life among patients with severe binocular visual field loss, future research should include a larger cohort of more severely affected patients. This strat¬ egy should also further the investigation ofa possible thresh¬ old of visual field impairment after which the relationship with questionnaire scores may change. If only some of the scales of the different questionnaires are proved to be valu¬ able in defining quality of life in patients with advanced visual field loss, then a composite questionnaire of the most discriminating questions could be constructed and used to retest those with milder disease.
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